You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Mallinckrodt
Dow
McKesson
Johnson and Johnson

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

Lithium carbonate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for lithium carbonate and what is the scope of freedom to operate?

Lithium carbonate is the generic ingredient in seven branded drugs marketed by Noven Therap, Able, Alembic Ltd, Apotex Inc, Glenmark Generics, Hetero Labs Ltd Iii, Hikma, Mylan, Usl Pharma, Watson Labs, Solvay, Jds Pharms, Alembic Pharms Ltd, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Mylan Pharms Inc, Unique Pharm Labs, Ani Pharms Inc, Bayer Pharms, Pfizer, and Sun Pharm Inds Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for lithium carbonate. Twenty-three suppliers are listed for this compound.

Drug Prices for lithium carbonate

See drug prices for lithium carbonate

Drug Sales Revenue Trends for lithium carbonate

See drug sales revenues for lithium carbonate

Recent Clinical Trials for lithium carbonate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
All India Institute of Medical Sciences, BhubaneswarPhase 4
StemCyte, Inc.Phase 2
Amarex Clinical ResearchPhase 2

See all lithium carbonate clinical trials

Pharmacology for lithium carbonate
Drug ClassMood Stabilizer
Medical Subject Heading (MeSH) Categories for lithium carbonate
Synonyms for lithium carbonate
2BMD2GNA4V
554-13-2
ACMC-209lmw
AK00285039
AKOS015904647
ANGC-554-13-2
ANW-32310
B7705
C07964
Camcolit
Candamide
Carbolith
Carbolithium
Carbolithium IFI
Carbolitium
Carbonic Acid Dilithium Salt
Carbonic acid lithium salt
Carbonic acid lithium salt (Li2CO3)
Carbonic acid, dilithium salt
Carbonic acid, lithium salt
Carbonic acid, lithium salt (1:2)
CCRIS 3153
Ceglution
CHEBI:6504
CHEMBL1200826
CLi2O3
CP 15467-61
CP-15,467-61
CP-15467-61
CP-1546761
CTK1G9703
D00801
DB14509
Dilithium carbonate
Dilithium Carbonate, Dilithium Salt, Carbonic Acid
dilithium trioxidocarbonate
DTXSID1023784
EC 209-062-5
EINECS 209-062-5
Eskalith
Eskalith (TN)
Eskalith CR
Eutimin
FT-0627895
GK3300
HSDB 3351
Hypnorex
I494
KS-0000025D
KSC269O0H
L0224
Li2 (C O3)
Li2CO3
Limas
Liskonum
Litard
Lithane
Lithea
Lithicarb
Lithinate
Lithionate
Lithium carbonate (2:1)
Lithium carbonate (JP17/USP)
Lithium carbonate (Li2CO3)
Lithium carbonate [USAN:JAN]
Lithium carbonate [USAN:USP:JAN]
Lithium Carbonate Nanoparticles
Lithium carbonate, 98+%, for analysis
Lithium carbonate, 99.999%, (trace metal basis), extra pure
Lithium carbonate, 99%, pure
Lithium carbonate, 99+%, ACS reagent
Lithium carbonicum
Lithium Phasal
Lithium QD
Lithium, Reference Standard Solution
Lithizine
Litho-Carb
Lithobid
Lithobid (TN)
Lithonate
Lithotabs
Liticar
LS-88061
Manialith
Maniprex
MFCD00011084
Micalith
Neurolepsin
NSC-16895
Pfi-lithium
Pfl-Lithium
Phasal
Plenur
Priadel
Q410174
Quilonorm
Quilonum retard
RTR-019539
Teralithe
Teralithe [French]
TR-019539
TRA0065195
UNII-2BMD2GNA4V
XGZVUEUWXADBQD-UHFFFAOYSA-L

US Patents and Regulatory Information for lithium carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharma LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076170-001 Jun 10, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma Intl Pharms LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076490-001 Jun 17, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Jds Pharms ESKALITH lithium carbonate TABLET;ORAL 017971-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glenmark Generics LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 079139-002 Feb 3, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Generics LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 079139-003 Feb 3, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan LITHIUM CARBONATE lithium carbonate CAPSULE;ORAL 076243-001 Jun 27, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer LITHIUM CARBONATE lithium carbonate TABLET;ORAL 016834-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Mallinckrodt
Dow
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.